Patents by Inventor Nabil Kerrouche

Nabil Kerrouche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION
    Publication number: 20260008859
    Abstract: Disclosed herein are methods for selectively treating atopic dermatitis (AD) in a subject having skin excoriations, pharmaceutical compositions for use in the treatment of atopic dermatitis in a subject having skin excoriations, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of atopic dermatitis in a subject having skin excoriations, and methods of identifying a subject having atopic dermatitis that is likely to respond to nemolizumab treatment or an equivalent thereof.
    Type: Application
    Filed: September 12, 2025
    Publication date: January 8, 2026
    Inventors: Nabil KERROUCHE, Keiko HIROKAWA, Ryosuke MIHARA
  • Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation
    Patent number: 12435147
    Abstract: Disclosed herein are methods for selectively treating atopic dermatitis (AD) in a subject having skin excoriations, pharmaceutical compositions for use in the treatment of atopic dermatitis in a subject having skin excoriations, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of atopic dermatitis in a subject having skin excoriations, and methods of identifying a subject having atopic dermatitis that is likely to respond to nemolizumab treatment or an equivalent thereof.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: October 7, 2025
    Assignees: Galderma Holding SA, Chugai Seiyaku Kabushiki Kaisha
    Inventors: Nabil Kerrouche, Keiko Hirokawa, Ryosuke Mihara
  • Use of ivermectin and brimonidine in the treatment and/or prevention of moderate to severe rosacea
    Patent number: 11213539
    Abstract: The present invention relates to a combination of ivermectin and brimonidine for use in the treatment and/or the prevention of moderate to severe rosacea, preferably by topical administration of a 1% ivermectin cream and 0.33% brimonidine gel.
    Type: Grant
    Filed: November 17, 2016
    Date of Patent: January 4, 2022
    Assignee: GALDERMA HOLDING SA
    Inventors: Philippe Martel, Nabil Kerrouche, Fabien Audibert
  • NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION
    Publication number: 20200385476
    Abstract: Disclosed herein are methods for selectively treating atopic dermatitis (AD) in a subject having skin excoriations, pharmaceutical compositions for use in the treatment of atopic dermatitis in a subject having skin excoriations, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of atopic dermatitis in a subject having skin excoriations, and methods of identifying a subject having atopic dermatitis that is likely to respond to nemolizumab treatment or an equivalent thereof.
    Type: Application
    Filed: August 7, 2020
    Publication date: December 10, 2020
    Inventors: Nabil KERROUCHE, Keiko HIROKAWA, Ryosuke MIHARA
  • USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA
    Publication number: 20180344757
    Abstract: The present invention relates to a combination of ivermectin and brimonidine for use in the treatment and/or the prevention of moderate to severe rosacea, preferably by topical administration of a 1% ivermectin cream and 0.33% brimonidine gel.
    Type: Application
    Filed: November 17, 2016
    Publication date: December 6, 2018
    Inventors: PHILIPPE MARTEL, NABIL KERROUCHE, FABIEN AUDIBERT
  • METHOD FOR TREATING SCARS WITH ADAPALENE 0.3%
    Publication number: 20180214401
    Abstract: A method is described for treating a scar with an effective amount of adapalene or salts thereof, which is administrated to the patient in need thereof. Optionally, the administered adapalene is in a quantity of 0.3% by weight relative to the total weight of the composition.
    Type: Application
    Filed: October 3, 2017
    Publication date: August 2, 2018
    Inventors: Pascale SOTO, Nabil KERROUCHE, Jean-Charles DHUIN
  • THERAPY REGIMEN FOR TREATING SEVERE ACNE RELATED DISEASES
    Publication number: 20160310512
    Abstract: A therapy regimen is described for the treatment of severe acne related diseases preferentially severe or nodular acne. The therapy regimen adds a topical fixed-dose combination of a retinoid and an anti-bacterial agent, such as benzoyl peroxide, to a course of oral antibiotic therapy using a daily dose of antibiotic ranging from 150 mg to 300 mg per day. Also described, is a fixed-dose combination of a retinoid and an anti-bacterial agent for use in the therapy regimen, and a kit suitable for implementing such therapy.
    Type: Application
    Filed: December 18, 2014
    Publication date: October 27, 2016
    Inventors: Fabien AUDIBERT, Nabil KERROUCHE, Pascale SOTO
  • MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE
    Publication number: 20160143876
    Abstract: A maintenance therapy regimen is described for the treatment of acne related diseases. The novel therapy regimen follows a course of oral antibiotic therapy with a topical fixed-dose combination of a retinoid, such as adapalene, and an anti-bacterial agent, such as benzoyl peroxide.
    Type: Application
    Filed: August 31, 2015
    Publication date: May 26, 2016
    Inventors: Jean-Charles DHUIN, Nabil KERROUCHE, Stéphanie ARSONNAUD, Pascale SOTO
  • Maintenance therapy regime/regimen for the treatment of acne
    Patent number: 9132139
    Abstract: A novel maintenance therapy regime/regimen for the treatment of acne related diseases includes administering an oral antibiotic with a topical fixed-dose combination of a retinoid, such as adapalene, and an anti-bacterial agent, such as benzoyl peroxide.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: September 15, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Charles Dhuin, Nabil Kerrouche, Stéphanie Arsonnaud, Pascale Soto
  • Concurrent therapy regime/regimen for the treatment of acne related diseases
    Patent number: 8853275
    Abstract: A novel therapy regime/regimen for the treatment of acne related diseases includes administering a topical fixed-dose combination of a retinoid and an anti-bacterial agent, such as BPO, to a course of oral antibiotic therapy.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: October 7, 2014
    Assignee: Galderma Research & Development
    Inventors: Jean-Charles Dhuin, Nabil Kerrouche, Stéphanie Arsonnaud, Pascale Soto
  • METHOD FOR TREATING SCARS WITH ADAPALENE 0.3%
    Publication number: 20130203850
    Abstract: A method is described for treating a scar with an effective amount of adapalene or salts thereof, which is administrated to the patient in need thereof. Optionally, the administered adapalene is in a quantity of 0.3% by weight relative to the total weight of the composition.
    Type: Application
    Filed: April 29, 2011
    Publication date: August 8, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Pascale Soto, Nabil Kerrouche, Jean-Charles Dhuin
  • USE OF A DERMATOLOGICAL COMPOSITION COMPRISING A COMBINATION OF ADAPALENE AND BENZOYL PEROXIDE WHICH IS INTENDED FOR THE TREATMENT OF ACNE IN NON-CAUCASIAN POPULATION WITH DECREASE OF POST-INFLAMMATORY HYPERPIGMENTATION
    Publication number: 20130131177
    Abstract: A dermatological composition including a combination of Adapalene and benzoyl peroxide is described. The composition is intended for the treatment of acne in the non-Caucasian population with decreased post-inflammatory hyperpigmentation, keloid scarring and acne hyperpigmented macules and cystic lesions.
    Type: Application
    Filed: February 3, 2011
    Publication date: May 23, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Charles Dhuin, Nabil Kerrouche, Pascale Soto
  • CONCURRENT THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE RELATED DISEASES
    Publication number: 20110183943
    Abstract: A novel therapy regime/regimen for the treatment of acne related diseases includes administering a topical fixed-dose combination of a retinoid and an anti-bacterial agent, such as BPO, to a course of oral antibiotic therapy.
    Type: Application
    Filed: May 18, 2009
    Publication date: July 28, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jean-Charles Dhuin, Nabil Kerrouche, Stéphanie Arsonnaud, Pascale Soto
  • MAINTENANCE THERAPY REGIME/REGIMEN FOR THE TREATMENT OF ACNE
    Publication number: 20110144003
    Abstract: A novel maintenance therapy regime/regimen for the treatment of acne related diseases includes administering an oral antibiotic with a topical fixed-dose combination of a retinoid, such as adapalene, and an anti-bacterial agent, such as benzoyl peroxide.
    Type: Application
    Filed: May 20, 2009
    Publication date: June 16, 2011
    Inventors: Jean-Charles Dhuin, Nabil Kerrouche, Stéphanie Arsonnaud, Pascale Soto